2019年12月份以來，我國新型冠狀病毒肺炎（COVID-19）確診病例急劇增加，引起全世界極大關(guān)注。面對嚴重的疫情，目前尚未發(fā)現(xiàn)特效藥物，但一些中藥復(fù)方在臨床上顯示出了明顯的療效，從這些中藥復(fù)方中尋找和開發(fā)用于治療COVID-19的天然藥物具有較強的可行性。根據(jù)《新型冠狀病毒肺炎診療方案（試行第六版）》中推薦使用的中藥復(fù)方，對各復(fù)方中藥材的使用頻數(shù)進行統(tǒng)計，并對統(tǒng)計結(jié)果中高頻數(shù)藥材的抗病毒研究進展進行綜述，以期為從中藥中篩選抗新型冠狀病毒（SARS-CoV-2）活性成分提供參考。

Since December 2019, there has been a sharp increase in the number of confirmed cases of pneumonia caused by the novel coronavirus (SARS-CoV-2) in China, which has caused great concern around the world. In face of severe epidemic, no specific drugs have been found in clinical practice. However, some Chinese medicine compounds have shown obvious clinical efficacy, and it is feasible to find and develop natural drugs for the treatment of novel coronavirus pneumonia from these compounds. In this paper, based on the recommends of new type of coronavirus infection pneumonia diagnosis and treatment scheme (trial version 6), the use frequency of Chinese herbal medicines was calculated. The antiviral reports of high frequency Chinese herbal medicines were reviewed, in order to provide the reference for screening the active components against SARS-CoV-2 from traditional Chinese medicine.

R183.3